Displaying 21–30 of 488 results
Jul 7, 2020 Eye On the Cure Research News
The goal of the partnership is to advance a PRPF31 gene therapy into a clinical trial
The Translational Research Acceleration Program (TRAP) awards will accelerate the movement of preclinical research toward an Investigational New Drug filing and into clinical trials to provide a robust and diverse pipeline of potential therapies to fight inherited retinal degenerations (IRD) and dry age-related macular degeneration.
Jul 6, 2020 Beacon Stories
Tracy was the fourth generation of his family to receive the diagnosis of retinitis pigmentosa, but he never let that stop him from dreaming big. Tracy has worked at NASA’s Johnson Space Center for over 36 years, making significant contributions over the many years.
Refsum disease is an inherited condition that causes vision loss, absence of the sense of smell, and a number of other symptoms.
Release Date: June 5, 2020 Expiration Date: May 29, 2023
This activity offers CE credit for: a. Physicians (CME) b. Optometrists (COPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™.
Recorded presentations from Virtual Visions 2020.
Jun 18, 2020 Eye On the Cure Research News
Treatment combines gene therapy and a device that generates and delivers retinal code
Jun 16, 2020 Press Releases
The national conference will be held virtually on June 25-27, providing the latest in science and research, practical adapting and thriving, and an opportunity to connect with others who are visually impaired.
Jun 15, 2020 Beacon Stories
Thirty-one-year-old Wren Blae Zimmerman always loved horses. But it wasn’t until a few years ago that Wren finally learned to ride. Now her life revolves around this equestrian dream, and she’s given herself the title of the “Blind Show Jumper.”
Jun 10, 2020 Eye On the Cure Research News
Microperimetry, which measures retinal sensitivity in the macular region, shows promise as outcome measure